Johnson & Johnson (JNJ)
Johnson & Johnson operates in the Drug Manufacturers - General industry of the Healthcare sector, headquartered in New Brunswick, NJ, US. The stock last traded at $268.04, up 0.85% on the session, giving a market capitalisation of $645.95B. On trailing twelve-month figures it carries a trailing P/E of 30.99, a net margin of 21.5%. Its beta of 0.23 implies it has historically moved less than the broad market.
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Johnson & Johnson is most often compared with the following Healthcare names: